NASDAQ: DTIL
Precision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?

Insider buying vs selling

Have Precision Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael AmorosoPresident and CEO2026-01-2234,799$4.17
$145.11kSell
John Alexander KellyChief Financial Officer2026-01-2115,213$4.03
$61.31kSell
J. Jefferson SmithChief Research Officer2026-01-2110,200$4.03
$41.11kSell
Dario ScimecaGeneral Counsel and Secretary2026-01-218,854$4.03
$35.68kSell
Stanley FrankelDirector2025-12-162,700$4.70
$12.69kBuy
Geno J. GermanoDirector2025-12-163,000$4.72
$14.16kBuy
Melinda BrownDirector2025-12-151,381$4.97
$6.86kBuy
Michael AmorosoPresident and CEO2025-11-033,409$6.49
$22.12kSell
Dario ScimecaGeneral Counsel and Secretary2025-11-03665$6.49
$4.32kSell
John Alexander KellyChief Financial Officer2025-11-031,303$6.49
$8.46kSell

1 of 3

DTIL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DTIL insiders and whales buy or sell their stock.

DTIL Shareholders

What type of owners hold Precision Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pharma Ag Novartis93.59%12,407,440$48.26MInsider
Venbio Global Strategic Fund LP32.17%4,265,141$16.59MInsider
Derek Jantz30.59%4,055,174$15.77MInsider
Fmr LLC28.20%3,738,248$14.54MInsider
Empery Asset Management LP16.55%2,194,635$8.54MInstitution
Aberdeen Group PLC16.13%2,138,603$8.32MInstitution
Matthew R. Kane15.27%2,024,438$7.88MInsider
Bleichroeder LP12.54%1,662,500$6.47MInstitution
Vanguard Group Inc6.84%906,782$3.53MInstitution
Alyeska Investment Group LP6.02%798,000$3.10MInstitution

1 of 3

DTIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DTIL24.85%75.15%Net SellingNet Selling
ACRV18.98%47.02%Net SellingNet Buying
INKT0.62%99.38%Net BuyingNet Buying
BYSI14.53%12.00%Net Selling
NRXS12.75%30.40%Net SellingNet Buying

Precision Biosciences Stock Ownership FAQ

Who owns Precision Biosciences?

Precision Biosciences (NASDAQ: DTIL) is owned by 68.90% institutional shareholders, 208.34% Precision Biosciences insiders, and 0.00% retail investors. Pharma Ag Novartis is the largest individual Precision Biosciences shareholder, owning 12.41M shares representing 93.59% of the company. Pharma Ag Novartis's Precision Biosciences shares are currently valued at $48.26M.

If you're new to stock investing, here's how to buy Precision Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.